| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Adaptive Biotechnologies Corporation (NASDAQ: ADPT)
ADPT Technical Analysis
5
| As on 9th Jun 2023 ADPT STOCK Price closed @ 7.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.36 & Strong Sell for SHORT-TERM with Stoploss of 18.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADPTSTOCK Price
| Open | 7.39 | Change | Price | % |
| High | 7.51 | 1 Day | -0.06 | -0.81 |
| Low | 7.19 | 1 Week | 0.35 | 5.03 |
| Close | 7.31 | 1 Month | 0.23 | 3.25 |
| Volume | 723400 | 1 Year | -22.04 | -75.09 |
| 52 Week High 29.35 | 52 Week Low 6.19 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ADPT Daily Charts |
ADPT Intraday Charts |
Whats New @ Bazaartrend |
ADPT Free Analysis |
|
|
ADPT Important Levels Intraday
| RESISTANCE | 7.93 |
| RESISTANCE | 7.73 |
| RESISTANCE | 7.61 |
| RESISTANCE | 7.48 |
| SUPPORT | 7.14 |
| SUPPORT | 7.01 |
| SUPPORT | 6.89 |
| SUPPORT | 6.69 |
ADPT Forecast May 2024
| 4th UP Forecast | 28.89 |
| 3rd UP Forecast | 21.97 |
| 2nd UP Forecast | 17.69 |
| 1st UP Forecast | 13.41 |
| 1st DOWN Forecast | 1.21 |
| 2nd DOWN Forecast | -3.07 |
| 3rd DOWN Forecast | -7.35 |
| 4th DOWN Forecast | -14.27 |
ADPT Weekly Forecast
| 4th UP Forecast | 13.84 |
| 3rd UP Forecast | 11.75 |
| 2nd UP Forecast | 10.45 |
| 1st UP Forecast | 9.16 |
| 1st DOWN Forecast | 5.46 |
| 2nd DOWN Forecast | 4.17 |
| 3rd DOWN Forecast | 2.87 |
| 4th DOWN Forecast | 0.78 |
ADPT Forecast2024
| 4th UP Forecast | 54.62 |
| 3rd UP Forecast | 39.45 |
| 2nd UP Forecast | 30.07 |
| 1st UP Forecast | 20.69 |
| 1st DOWN Forecast | -6.07 |
| 2nd DOWN Forecast | -15.45 |
| 3rd DOWN Forecast | -24.83 |
| 4th DOWN Forecast | -40 |
Adaptive Biotechnologies Corporation ( NASDAQ USA Symbol : ADPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADPT Business Profile
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It also has a research collaboration with Curebase, Inc. to enhance patient participation in clinical studies. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington. Address: 1165 Eastlake Avenue East, Seattle, WA, United States, 98102
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service